ClinicalTrials.Veeva

Menu

Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Perennial Allergic Rhinitis

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Perennial Allergic Rhinitis

Treatments

Procedure: sham acupuncture
Procedure: SPA acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT04234451
SPA acupuncture for PAR

Details and patient eligibility

About

In recent years, a number of randomized controlled trials have confirmed the efficacy and safety of acupuncture in the treatment of allergic rhinitis (AR). Indeed, the latest American clinical guidelines recommended acupuncture treatment for AR patients who are interested in non-pharmacological treatment.

In conventional acupuncture treatment for AR, needles are inserted at specific acupoints in the body; with several studies demonstrating acupuncture of sphenopalatine ganglion (SPG) to improve nasal symptoms and quality of life in nasal inflammatory diseases.

The investigators hypothesize that, compared with sham acupuncture and rescue medication (RM), active SPG acupuncture combined with RM would lead to greater improvements in symptoms score and reduction in overall need for antihistamines. To test this hypothesis the investigators design a randomized, double blind, controlled trial to evaluate the efficacy of SPG acupuncture in perennial AR patients (allergic to indoor allergens, including house dust mite, fungi, animal dander and so one) and to explore the potential underlying mechanisms.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. history of physician-diagnosed PAR with at least 2 years of typical symptoms
    1. course on each onset lasting at least 4 weeks
    1. skin prick test and/or serum antigen specific IgE positive to indoor allergens(sIgE≥0.7kU/L,≥class 2)
    1. good patient compliance on acupuncture treatment
    1. total nasal symptom scores(TNSS)>6 at V0

Exclusion criteria

    1. oral steroids within 4 weeks prior to recruitment
    1. nasal steroids and/or antihistamine 2 weeks prior to recruitment
    1. seasonal AR
    1. any respiratory infection within the previous 4 weeks prior to recruitment
    1. history of nasal polyps, nasal septum deviation, asthma or autoimmune disorders
    1. previously received acupuncture therapy for AR within 1 month prior to recruitment
    1. women during pregnancy or lactation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

SPA acupuncture
Active Comparator group
Description:
active SPG acupuncture plus rescue medication (AA group)
Treatment:
Procedure: SPA acupuncture
sham acupuncture
Sham Comparator group
Description:
sham-SPG acupuncture plus rescue medication (SA group)
Treatment:
Procedure: sham acupuncture

Trial contacts and locations

1

Loading...

Central trial contact

Hongfei Lou; Chengshuo Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems